Notice2022-01740
National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 28, 2022
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 19 (Friday, January 28, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 19 (Friday, January 28, 2022)]
[Notices]
[Pages 4632-4633]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-01740]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel; P41 NCBIB Review F-SEP.
Date: March 3, 2022.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dennis Hlasta, Ph.D., Scientific Review Officer,
National Institute of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707 Democracy Blvd., Bethesda, MD
20892, (301) 451-4794, <a href="/cdn-cgi/l/email-protection#3551505b5b5c461b5d5954464154755b5c5d1b525a43"><span class="__cf_email__" data-cfemail="3450515a5a5d471a5c5855474055745a5d5c1a535b42">[email protected]</span></a>.
Name of Committee: National Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel; P41 NCBIB Review B-SEP.
[[Page 4633]]
Date: March 14, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Plaza, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ruixia Zhou, Ph.D., Scientific Review Officer,
National Institute of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707 Democracy Blvd., Suite 957,
Bethesda, MD 20892, (301) 496-4773, <a href="/cdn-cgi/l/email-protection#770d1f180205371a161e1b59191e1f59101801"><span class="__cf_email__" data-cfemail="b9c3d1d6cccbf9d4d8d0d597d7d0d197ded6cf">[email protected]</span></a>.
Name of Committee: National Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel; Blueprint MedTech U54 (PAR21-
314).
Date: March 21, 2022.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Plaza, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: John K. Hayes, Ph.D., Scientific Review Officer,
National Institute of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707 Democracy Blvd., Suite 959,
Bethesda, MD 20892, (301) 451-3398, <a href="/cdn-cgi/l/email-protection#97fff6eef2e4fdd7faf6fefbb9f9feffb9f0f8e1"><span class="__cf_email__" data-cfemail="9cf4fde5f9eff6dcf1fdf5f0b2f2f5f4b2fbf3ea">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.866,
National Institute of Biomedical Imaging and Bioengineering,
National Institutes of Health, HHS)
Dated: January 24, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-01740 Filed 1-27-22; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on January 28, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.